Clinical stage biotechnology company PharmAust has received commitments to raise $10 million via an institutional placement with directors and...
Vous n'êtes pas connecté
PharmAust raises $10m to finalise preparations for its pivotal adaptive Phase 2/3 STRIKE study. ...
Clinical stage biotechnology company PharmAust has received commitments to raise $10 million via an institutional placement with directors and...
Alnylam (ALNY) soars as its phase III study, seeking to expand Anvuttra's label to include the treatment of ATTR amyloidosis with cardiomyopathy,...
Radiopharm Theranostics’ stock rocketed up 35 per cent this morning after the cancer-fighting company secured commitments from leading investors to...
Sidara has recently notified Wood that it requires more time to finalise its due diligence and other preparations regarding the proposed takeover of...
SaaS company InteliCare Holdings (ASX:ICR) raises $2m, setting the stage for a new phase of commercialisation after a year of ...
Mesoblast (MESO) skyrockets 208.2% year to date on encouraging progress with its pipeline candidates.
Mesoblast (MESO) skyrockets 208.2% year to date on encouraging progress with its pipeline candidates.
Samsung Electronics revealed the date for its forthcoming Galaxy Unpacked, promoting announcements set to be made as heralding a new phase in mobile...
The US Army and Botswana Defence Force (BDF) have concluded the final planning conference for exercise Southern Accord 2024, which takes place from...
Allora Labs, previously known as Upshot and renowned for NFT valuations, has recently concluded a significant funding round, raising 3 million dollars...